Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 08, 2023

Comparative Risk of Angioedema With Sacubitril–Valsartan vs RAAS Inhibitors

Journal of the American College of Cardiology


Additional Info

Journal of the American College of Cardiology
Comparative Risk of Angioedema With Sacubitril-Valsartan vs Renin-Angiotensin-Aldosterone Inhibitors
J Am Coll Cardiol 2023 Jan 31;81(4)321-331, E Eworuke, EC Welch, N Haug, C Horgan, HS Lee, Y Zhao, TY Huang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading